Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
38.85
+0.61 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
38.50
-0.35 (-0.90%)
After-hours: Jun 26, 2026, 7:15 PM EDT
Immunovant Employees
Immunovant had 315 employees as of March 31, 2026. The number of employees decreased by 47 or -12.98% compared to the previous year.
Employees
315
Change (1Y)
-47
Growth (1Y)
-12.98%
Revenue / Employee
n/a
Profits / Employee
-$1,605,098
Market Cap
7.98B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Corcept Therapeutics | 730 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Kymera Therapeutics | 253 |
| Praxis Precision Medicines | 168 |
IMVT News
- 4 weeks ago - Immunovant price target raised to $47 from $35 at JPMorgan - TheFly
- 4 weeks ago - Immunovant price target raised to $62 from $44 at Guggenheim - TheFly
- 5 weeks ago - Immunovant price target raised to $30 from $23 at Truist - TheFly
- 5 weeks ago - Immunovant price target raised to $43 from $32 at BofA - TheFly
- 5 weeks ago - Immunovant price target raised to $40 from $35 at H.C. Wainwright - TheFly
- 5 weeks ago - Immunovant rises 33.6% - TheFly
- 5 weeks ago - This Is Why Immunovant Stock (IMVT) Is Up Today - TipRanks
- 5 weeks ago - 2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug - Barrons